Palatin Technologies (LTS:0KF3) EBIT per Share : $-2.71 (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Palatin Technologies EBIT per Share?

Palatin Technologies's EBIT per Share for the three months ended in Mar. 2024 was $-0.53. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.71.

During the past 3 years, the average EBIT per Share Growth Rate was -5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Palatin Technologies's EBIT per Share or its related term are showing as below:

LTS:0KF3' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -25.4 Med: 17.9 Max: 57.2
Current: -5.8

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Palatin Technologies was 57.20% per year. The lowest was -25.40% per year. And the median was 17.90% per year.

LTS:0KF3's 3-Year EBIT Growth Rate is ranked worse than
61% of 1305 companies
in the Biotechnology industry
Industry Median: 3.5 vs LTS:0KF3: -5.80

Palatin Technologies's EBIT for the three months ended in Mar. 2024 was $-8.43 Mil.

Palatin Technologies EBIT per Share Historical Data

The historical data trend for Palatin Technologies's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palatin Technologies EBIT per Share Chart

Palatin Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT per Share

Get a 7-Day Free Trial

4.17

-2.39

-3.55

-3.79

-2.96

Palatin Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-0.76	-1.14	-0.48	-0.56	-0.53

Palatin Technologies EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Palatin Technologies's EBIT per Share for the fiscal year that ended in Jun. 2023 is calculated as

	EBIT per Share		(A: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-32.197	/	10.890
=	-2.96

Palatin Technologies's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-8.434	/	15.792
=	-0.53

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.71

Palatin Technologies (LTS:0KF3) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Palatin Technologies EBIT per Share Related Terms

Thank you for viewing the detailed overview of Palatin Technologies's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Palatin Technologies (LTS:0KF3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palatin Technologies Inc (LTS:0KF3) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

PTN:USA PTN:Germany PTN:Germany

Address

4B Cedar Brook Drive, Cranbury, NJ, USA, 08512

Website

https://www.palatin.com

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.

Palatin Technologies (LTS:0KF3) Headlines

No Headlines